Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Megan Driscoll, CEO of PharmaLogics Recruiting Becomes 1 of Only 750 Other Female CEO’s on the 2014 Inc. 5000 List of America’s Fastest-Growing Private Companies
Ranked No. 2077 with a Three-Year Sales Growth of 193% - September 10, 2014 - PharmaLogics Recruiting
Xeno Diagnostics Adds Dr. Daniel Wierda as Director of Research and Development
Addition of Top Talent Strengthens Fast-Growing Indianapolis Biotech CRO - September 10, 2014 - Xeno Diagnostics, LLC
Medic East Africa: East Africa’s Largest Healthcare Exhibition and Congress Maintains Its Prominent Presence on the Continent
The Visa Oshwal Convention Centre in Nairobi will once again host the 2nd Medic East Africa Exhibition & Congress (MEA), which is the largest healthcare event in East Africa to date, and exclusively supported by the Ministry of Health. This year's event will take place from 23-25 September 2014... - September 06, 2014 - Informa Life Sciences
Sengenics Launches Sequenom’s New Non-Invasive Prenatal VisibiliT Test in Three Additional Territories in Asia
Sengenics, a leading molecular diagnostics and research company in the region, today announced the launch of VisibiliT, Sequenom's new low-cost, non-invasive, prenatal test. After successfully launching the MaterniT21 prenatal test in November 2012 in Singapore and Malaysia, Sequenom has chosen... - September 02, 2014 - Sengenics
Creative Biomart Newly Released a Bunch of Over-Expression Lysates
Official marketing staff of Creative Biomart has announced today of their new products release for over-expression lysates. According to its official announcement, this new release is mainly an enhancement of their lysates product. Nearly 9,000 of products have been added in this launch such as... - September 02, 2014 - Creative Biomart
Affinity Biologicals Presents New Health Canada & CE Marked Plasmas for Diagnostic Use and Hemostasis Research in Canada & Europe
Affinity Biologicals Inc., a leading name in diagnostics and research, especially hemostasis research, has recently announced the launching of their new Factor Deficient Plasma page that features their new Health Canada and CE Marked plasmas. - August 29, 2014 - Affinity Biologicals
NC COIN Promotes Karen Shank to Business Development Director
Pharma, Software, and Medical Technology Veteran Developing K-12 Programming, Expanding Membership Base of Nonprofit Idea Accelerator - August 27, 2014 - COIN
Creative Biomart Introduced Immobilized Enzyme Service
On August 24, 2014, Creative Biomart has introduced their novel service of immobilized enzymes. This novel service is based on a revolutionary new platform, combining affinity tag binding with inert porous materials, designed especially for biocatalysis application in any organic solvent or... - August 27, 2014 - Creative Biomart
Braasch Biotech to Participate at Informa's 9th Annual Veterinary Vaccine Conference
Braasch's Biotech's Dr. Keith Haffer to host seminar on adjuvants at Informa's Veterinary Vaccine Conference in December. - August 25, 2014 - Braasch Biotech LLC
Cheers—Creative Biomart Launches High-Throughput Protein Production
The marketing chief staff of Creative Biomart has announced today that they will release the high-throughput protein production service on this very day in the aim of helping speed up their customer’s protein production project. Protein expression is widely used in the production of... - August 22, 2014 - Creative Biomart
Creative Biomart Launches Novel Service for Protein Labeling
On August 18, Creative Biomart had launched a novel service that is site-specific and custom labeling for protein labeling. This new service includes C-terminal labeling, N-terminal labeling, and Labeling at glycosylation sites. The launch of the site-specific and custom labeling service was said... - August 22, 2014 - Creative Biomart
Affinity Biologicals Introduce Upgraded Collection of VisuLize™ Antigen ELISA Kits
ELISA, otherwise known as the enzyme-linked immunosorbent assay, is a test that detects the presence of a certain substance, generally an antigen, by monitoring antibodies and colour change. - August 21, 2014 - Affinity Biologicals
Creative Biomart Signed Industrial Enzymes Agreement
Creative Biomart signed an Industrial Enzymes Agreement with a UK Industrial giant (the name of the company is not allowed to be exposed according to the agreement). On the basis of this agreement, Creative Biomart is going to provide High-temperature Alpha-amylase for beer, Mid-temperature... - August 20, 2014 - Creative Biomart
Biological Drugs Market Will Reach USD 2, 87,139.7 Million in 2019, Globally: Persistence Market Research
Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020 - Persistence Market Research - August 19, 2014 - Persistence Market Research
Epitope Diagnostics, Inc. Introduces New 2-Hour Human ACTH ELISA Kit
Epitope Diagnostics releases a new, highly sensitive and robust human ACTH ELISA kit which can be completed in 2 hours, increasing the efficiency of clinical laboratory operations. - August 19, 2014 - Epitope Diagnostics, Inc.
MMS Holdings and Oncology Trials Insights Form Strategic Partnership to Deliver Comprehensive Oncology Support Services
MMS Holdings Inc., a global clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries, and Oncology Trials Insights (OTI), an organization of oncology key opinion leaders that architect superior clinical trial... - August 18, 2014 - MMS Holdings Inc.
Creative Diagnostics Expands Its Antibody Pairs Offering
By the time of the release, Creative Diagnostics has expanded its antibody pairs to over 40,000. - August 14, 2014 - Creative Diagnostics
World Genomics Market is Expected to Reach USD 22.1 Billion by 2020: by Grand View Research, Inc
Grand View Research Has Announced the latest Addition of "Global Genomics Market Trends & Forecasts To 2020" Market Research Report to Their Database. - August 14, 2014 - Grand View Research
BioGenex Opens European Office in Milan, Italy
A global market leader in fully-automated Molecular Pathology Systems, BioGenex, opens European office in Milan, Italy. - August 03, 2014 - BioGenex
BioGenex Launches New Website
A global market leader in fully-automated Molecular Pathology Systems, BioGenex, launches a new website for its customer’ worldwide. - August 03, 2014 - BioGenex
ETR Laboratories Names Lab Manager
Environmental Testing and Research Laboratories is pleased to announce that Ramakanth Ananthoji, PhD, has assumed the position of Laboratory Manager. Ananthoji comes to ETR Laboratories with a broad level of experience including leadership, management and technical work in both a laboratory and... - August 01, 2014 - Environmental Testing and Research Laboratories, Inc.
Creative Diagnostics Expands Database of Antibody Pairs
The expanding of Creative Diagnostics' database of antibody pairs could largely save the preparation time of investigators. - August 01, 2014 - Creative Diagnostics
Chinese Pharma Growth Remains Impressive in 2013-2014 Despite Challenges and Crackdowns
By large, the Chinese pharmaceutical sector still saw double-digit growth in 2013 and the first half of 2014 despite a host of challenges stemmed from slowing Chinese economy, regulatory shakeups, cost containment measures and price cuts, as well as healthcare reform turbulences, according to the... - July 25, 2014 - WiCON International Group LLC
Creative Diagnostics Announces New Big Promotion Activity for Antibodies
Creative Diagnostics's July Big Promotion is open to customers around the world. - July 22, 2014 - Creative Diagnostics
Mark Bunnage to Speak at Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston)
Mark Bunnage, Vice President, Head of Chemistry Biotherapeutics Research at Pfizer to Give a Keynote Presentation at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA) - July 13, 2014 - GTCbio
Pathology Diagnostics Ltd (PDL) Launches New Immunofluorescence Capabilities
Pathology Diagnostics has embraced the invaluably powerful technique of immunofluorescence (IMF); utilising fluorescent-labelled antibodies to detect specific target antigens. - July 11, 2014 - Pathology Diagnostics Ltd
Hormel Foods Specialty Products Division and VIRUN®, Granted Patent No. 8,741,373
VIRUN® and the Specialty Products Division at Hormel Foods were granted Patent number 8,741,373, Composition for Non-Polar Compounds. This particular patent allows unwavering high oil load encapsulation of non-polar compounds, such as Omega-3 EPA and DHA, CoQ10, Vitamins A, D, E, K, Carotenoids such as Lutein, Beta Carotene or Astaxanthin into certain water soluble and stable foods and beverages. - July 09, 2014 - VIRUN
Recursion Pharmaceuticals Announces Funding for Rett Syndrome Research
Recursion Pharmaceuticals has received support for focused work to identify a treatment for Rett Syndrome by the Rett Syndrome Research Trust. Recursion will apply its innovative drug discovery platform immediately to investigate the gene MECP2 in an effort to identify new therapeutics for the condition. - July 09, 2014 - Recursion Pharmaceuticals
Jianxin Zhang, Sanofi Pasteur, to Speak at Protein-Protein Interaction, Oct. 23-24, 2014 in Boston
Jianxin Zhang, Deputy Director of Protein Characterization at Sanofi Pasteur to Speak at 2nd Protein-Protein Interaction Conference, October 23-24, 2014 in Boston, MA. - July 06, 2014 - GTCbio
Nic Angell at Amgen to Speak at Protein Expression, Purification, Characterization Oct 23-24, 2014
Nic Angell, Principal Scientist, Process Development at Amgen to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA. - July 05, 2014 - GTCbio
Nathanael Gray to Speak at 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA)
Nathanael Gray, Professor, Biological Chemistry and Molecular Pharmacology, Dana Farber Cancer Institute, Harvard Medical School to Give a Featured Presentation at the 3rd Protein Kinases & Drug Design Conference (Oct 23-24, 2014 in Boston, MA). - July 05, 2014 - GTCbio
Affinity Biologicals Now Offers a Variety of Elisa Kits Aimed at Thrombosis Research
Significant New Innovations by Affinity Biologicals Promise to Greatly Extend Assay Sensitivity and ELISA’s Range of Capabilities - July 04, 2014 - Affinity Biologicals
A Lay Person's Guide to the Hobby Lobby Decision
Today, Saltbox Consulting published A Lay Person's Guide to the Hobby Lobby Decision. The guide is designed to help non-lawyers understand the Hobby Lobby decision, which the Supreme Court released on June 30, 2014. It explains in plain English what the issues were, how the Court decided them and... - July 02, 2014 - Saltbox Consulting
Pathology Diagnostics Ltd (PDL) Biomarker Test Portfolio and Advanced Staining Capabilities Show CAGR of 50%
Due to the recent rapid growth of Pathology Diagnostics Ltd (PDL), the advanced laboratory staining biomarker test portfolio of the organisation has grown at an extremely impressive rate, with the number of biomarkers validated now reaching over 370 for immunohistochemistry (IHC) and... - June 27, 2014 - Pathology Diagnostics Ltd
AveXis Announces Dosing of First Patient for Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 at Nationwide Children’s Hospital
AveXis, Inc., a synthetic biology platform company, today announced that the first patient in the Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 has now been enrolled and dosed by Nationwide Children’s Hospital. This trial utilizes chariSMA, the gene therapy product developed... - June 26, 2014 - AveXis Inc.
BioClosure(R) Container Seals from AdvantaPure(R) Now Available in Silicone and TPE for Glass, Metal or Plastic Containers
Container closures made not only from silicone but now from AdvantaFlex TPE are available from high purity tubing manufacturer AdvantaPure. Called BioClosures, the products provide a sure seal for containers used in biopharmaceutical and other critical industries. TPE offers advantages over silicone such as lower absorption rates, along with the benefit of being free of silicone oils. When used as single use components, TPE BioClosures reduce contamination risks and cleaning requirements. - June 25, 2014 - NewAge Industries, Inc.
Dr. William D. Bowers Awarded Certification by ABVLM
Dr. William D. Bowers is awarded an exclusive, ten-year certification to elite medical practitioners from the American Board of Venous & Lymphatic Medicine (ABVLM) in the field of Venous & Lymphatic Medicine. - June 24, 2014 - Bowers Vein Institute
Colorado BioScience Association Releases Annual Bioscience Colorado Magazine at BIO International Convention in San Diego
Colorado BioScience Association (CBSA) is releasing its annual edition of Bioscience Colorado, this week, at the BIO International Convention in San Diego, CA. Bioscience Colorado is a key resource for companies, investors and economic developers, and has become the go-to source for the industry. - June 23, 2014 - Colorado BioScience Association
Pathology Diagnostics Ltd (PDL) Launches Social Media Presence Online
Having already established itself as one of the leaders in its industry, Pathology Diagnostics is continuing to grow from strength to strength – evolving into a formidable organisation within its market space. Wanting to showcase its employee expertise (both academic and industry-applied) and... - June 22, 2014 - Pathology Diagnostics Ltd
Robert Murphy Speaks at Cell Based Assay Conf., Oct 7-8, 2014, Dublin, Ireland
Robert Murphy, Carnegie Mellon University, to Give Keynote Address at Cell Based Assay & Screening Technologies Conference, October 7-8, 2014 in Dublin, Ireland. - June 22, 2014 - GTCbio
AveXis to Present at Piper Jaffray GenomeRX Symposium
AveXis, a clinical stage synthetic biology platform company, today announced that Mr. John Carbona, Chief Executive Officer and other members of the AveXis team will participate in the panel discussion “The Power Alley: Gene Therapy For Neuromuscular Disorders” at the Piper Jaffray... - June 20, 2014 - AveXis Inc.
Chih-Jen (CJ) Wei, Sanofi Pasteur to Present at Vaccines Conference on July 9-11, 2014, in Boston, MA
Chih-Jen (CJ) Wei, Director at Sanofi Pasteur to Present at the 12th Vaccines Research & Development: All Things Considered Conference on July 9-11, 2014, in Boston, MA. - June 19, 2014 - GTCbio
Katarina Radosevic, Janssen to Present at Vaccines Conference on July 9-11, 2014, in Boston, MA
Katarina Radosevic, Vice President Immunology and Proof of Concept, Head Vaccine Discovery at Crucell Vaccine Institute, Janssen Center of Excellence for Immunoprophylaxis will give a presentation on, “Prospects for Universal Influenza Vaccine” at the 12th Vaccines Research &... - June 19, 2014 - GTCbio
Arnold S. Monto to Keynote at Influenza Conference on July 9-11, 2014, in Boston, MA
Dr. Arnold S. Monto, Thomas Francis Jr. Collegiate Professor, University of Michigan School of Public Health’s Department of Epidemiology to give a keynote presentation on, “Controversies in Influenza Control: Are They Real?” at the 3rd Annual Influenza Research and Development... - June 19, 2014 - GTCbio
Kathleen Coelingh, MedImmune to Speak at Influenza R&D Conference on July 9-11, 2014, in Boston, MA
Kathleen Coelingh, Senior Director, Medical Affairs at MedImmune to Give a Presentation on, “Development of Pandemic Live Attenuated Influenza Vaccines” at the 3rd Annual Influenza Research and Development Conference on July 9-11, 2014, in Boston, MA, by GTCbio. Dr. Coelingh will... - June 19, 2014 - GTCbio
Special Big Pharma Panel to be Held at CNS Diseases Summit, Sept 18-19, 2014, SF
Panel discussion on “What Sells Big Pharma in CNS Diseases?” to be held at the CNS Diseases World Summit, Sept. 18-19, 2014 in San Francisco, CA - June 19, 2014 - GTCbio
Dale Steichen, AkzoNobel, to Keynote at Biobased Chemicals Conference (Sep 18-19, 2014 in SF, CA)
Dale Steichen, AkzoNobel to Give Keynote Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (September 18-19, 2014 in San Francisco, CA) - June 17, 2014 - GTCbio
Molekule Consulting Inc. to Present and Exhibit at the Pharma Competitive Intelligence Conference & Exhibition USA – September 9-10, 2014 Parsippany, NJ
Molekule Consulting Inc. (“Molekule”) today announces its exhibiting at the 2014 Pharma Competitive Intelligence Conference & Exhibition USA – September 9-10, 2014 Parsippany, NJ. - June 13, 2014 - Molekule Consulting Inc.
Future Genesis (FGen) Announces Deal with Biomedical Research Institute (BRI)
Future Genesis (FGen) has selected Rockville, MD Biomedical Research Institute (BRI) as its cryogenic laboratory. - June 12, 2014 - Future Genesis, Inc.
IonSense Introduces the DART®-EDU Program to Provide Educational Institutions with an Economical Path to Ownership of Its State-of-the-Art Mass Spectrometry Technology
Educational Leasing Program will enable chemistry departments to lower operating costs while providing students access to Direct Analysis in Real Time Mass Spectrometry. To be exhibited at the 62nd ASMS Conference on Mass Spectrometry and Allied Topics in Baltimore, MD, June 15-19, 2014, Booth 120. - June 10, 2014 - IonSense, Inc.